REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $843 | -99.9% | 45,659 | +6.2% | 0.10% | +18.0% |
| Q2 2022 | $594,000 | -54.7% | 42,978 | -36.1% | 0.09% | -49.4% |
| Q1 2022 | $1,311,000 | +80.6% | 67,232 | +174.4% | 0.18% | +114.6% |
| Q2 2021 | $726,000 | +60.6% | 24,498 | -19.9% | 0.08% | -27.4% |
| Q1 2020 | $452,000 | +115.2% | 30,574 | +192.5% | 0.11% | +370.8% |
| Q4 2018 | $210,000 | -48.3% | 10,451 | -29.4% | 0.02% | +20.0% |
| Q2 2018 | $406,000 | – | 14,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |